Paper Titles

Use of Data Mining Techniques to Detect Medical Fraud in Health Insurance
p.1574

Application of Electronic Nose Technology in Breath Tests for Patients with Diabetes
p.1579

Efficient RPM Method for Detecting R and S Waves of ECG Signals
p.1584

A Bridging Method between 2D and 3D Cephalometry Using Computed Tomography Synthesized Cephalograms
p.1589

A Novel Approach to Predict Schizophrenia Disease: Conceptual Framework
p.1596

A Study on the Control of Bio-Aerosol for Prevention of Indoor Aerial Infection Using Antimicrobial Air Filter
p.1601

An Application of CLPFG for Detecting Diabetes Mellitus
p.1606

An Expert System for 2D Stress Analysis of Human Teeth
p.1611

An FPGA-Based Brain-Computer Interface for Wireless Electric Wheelchairs
p.1616

HomeApplied Mechanics and MaterialsApplied Mechanics and Materials Vols. 284-287A Novel Approach to Predict Schizophrenia Disease:...

A Novel Approach to Predict Schizophrenia Disease: Conceptual Framework

Article Preview

Abstract:

A multilayer perceptrons (MLP) is proposed to aid in early detection of schizophrenia in this study. Schizophrenia is a disabling illness with unknown pathogenesis. Clinical studies have shown that there is a genetic contribution to the pathogenesis of schizophrenia. The transcription factor 4 (TCF4) gene, vaccinia-related kinase 2 (VRK2) gene as well as other five genes which were newly-identified loci of 1p21.3, 2p32.3, 8pp23.3, 8q21.3 and 10q24.32-p22.1 are among the most prominent susceptibility genes for schizophrenia. It has been hypothesized that TCF4 affects normal brain development and it has been related to different forms of neurodevelopmental disorders. Despite numerous linkage and association analyses (haplotype and meta analyses), the seven gene polymorphisms that contribute to schizophrenia remain to be elucidated. Using a haplotype block-based gene-tagging approach we will conduct an association study of thirty single nucleotide polymorphisms (SNPs) of the above seven gene polymorphisms. Artificial Neural Networks (ANNs) are widely used in prediction application. This research work will demonstrate that the MLP based prediction of schizophrenia which used genetic data (simple combination of thirty genotypic frequencies) of thirty SNPs to improve the detection possibility and accuracy with high consistency. This ANN is expected to exhibit good performance in the prediction of schizophrenia.

You might also be interested in these eBooks

Innovation for Applied Science and Technology

Info:

Periodical:

Applied Mechanics and Materials (Volumes 284-287)

Pages:

1596-1600

DOI:

https://doi.org/10.4028/www.scientific.net/AMM.284-287.1596

Citation:

Cite this paper

Online since:

January 2013

Authors:

Han Chern Loh

Keywords:

Artificial Neural Network (ANN), Multilayer Perceptrons, Prediction, Schizophrenia

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] R. Tandon, M.S. Keshavan and H.A. Nasrallah: Schizophr. Res. Vol. 102 (2008), p.1

[2] S.G. Schwab and D.B. Wildenauer: Schizophr. Res. Vol. 102 (2008), p.29

[3] National Mental Health Registry: National Mental Health Registry Schizophrenia Report 2003 – 2005 (Kuala Lumpur: National Mental Health Registry Publication, Malaysia 2006).

DOI: 10.1002/mhw.30831

[4] T.J. Chow and H.C. Loh: Sains Malaysiana Vol. 40 (2011), p.1319

[5] L.B. Othmen, A. Mechri, C. Fendri, M. Bost, G. Chazot, L. Gaha and et al.: Prog. Neuro-Psychopharmacol. Biol. Psychiatry Vol. 32 (2008), p.155

DOI: 10.1016/j.pnpbp.2007.08.003

[6] R.D. Srous and Y. Shoenfeld: Journal of Autoimmunity Vol. 27 (2006), p.71

[7] N. Muller and M.J. Schwarz: Curr Immunol Rev. Vol. 6 (2010), p.213

[8] D.K. Kinney, K. Hintz, E.M. Shearer, D.H. Barch, C. Riffin, K. Whitley and R. Butler: Medical Hypotheses Vol. 74 (2010), p.555

DOI: 10.1016/j.mehy.2009.09.040

[9] R.C. Drexhage, E.M. Knijff, R.C. Padmos, L. van der Heul-Nieuwenhiujzen, W. Beumer, M.A. Versnel and H.A. Drexhage: Expert Rev. of Neurotherapeutics Vol. 10 (2010), p.59

DOI: 10.1586/ern.09.144

[10] D. Samaroo, R. Dickerson, D.D. Kasarda, P.H.R. Green, C. Briani, R.H. Yolken, A. Aleadini: Schizophr. Res. Vol. 118 (2010), p.248

[11] Freudenreich, M.A. Brockman, D.C. Henderson, A.E. Evins, X. Fan, J.P. Walsh, D.C. Goff: Psychiatry Res. Vol. 176 (2010), p.99

[12] P.F. Sullivan, K.S. Kendler, M.C. Neale: Archives of General Psychiatry Vol. 60 (2003), p.1187

[13] M. Gelder, R. Mayou, and J. Geddes: Psychiatry (Oxford University Press Inc., New York: 2006).

[14] S. Prasad, P. Semwal, S. Deshpande, T. Bhatia, V.L. Nimgaonkar and B.K. Thelma: J. Biosci. Vol. 27 (2002), p.35

[15] Schizophrenia Psychiatric GWAS Consortium: Nature Genetics. Vol. 43 (2011), p.969

[16] T.J. Chow, S.F. Tee, P.Y. Tang and H.C. Loh: Asian Journal of Psychiatry Vol. 3 (2010), p.190

[17] Y. Kim, S. Zerwas, S.E. Trace and P.F. Sullivan: Schizophr. Bull. Vol. 37 (2011), p.456

[18] S.B. Powell, T.J. Sejnowski and M.M. Behrens: Neuropharmacology Vol. 62 (2012), p.1322

[19] C. Miljevic, C. Crnobaric, B. Vidovic, B. Djordjevic and D. Lecic-Tosevski: Internal Clinical Psychopahrmacology Vol. 26 (2011), p. e171

DOI: 10.1097/01.yic.0000405937.19426.ab

[20] C. Ran, M. Westerlund, A. Anvret, T. Willows, O. Sydow, D. Galter and A. C. Belin: Neuroscience Letters Vol. 501 (2011), p.41

DOI: 10.1016/j.neulet.2011.06.038

[21] S.F. Tee, P.Y. Tang and H.C. Loh: Psychiatry Res. Vol. 195 (2012), p.83

[22] H.C. Loh, P.Y. Tang, S.F. Tee , T.J. Chow, Y.C. Cheah and S.S.J. Singh: Genet. Mol. Res. Vol. 11 (2012), p.725

[23] S.F. Tee, P.Y. Tang and H.C. Loh: Genet. Mol. Res. Vol. 10 (2011), p.1850

[24] S.F. Tee, T. J. Chow, P.Y. Tang and H.C. Loh: Genet. Mol. Res. Vol. 9 (2010), p.1274

[25] H.C. Loh, P.Y. Tang, S.F. Tee and T.J. Chow: submitted to Psychiatry Res. (2012).

[26] D.J. Blake, M. Forrest, R.M. Chapman, C.L. Tinsley, M.C. O'Donovan and M.J. Owen: Schizophr. Bull. Vol. 36 (2010), p.443

[27] T. Li, Z. Li,P. Chen, Q. Zhao, T. Wang, K. Huang and et al.: Biol. Psychiatry Vol. 68 (2010), p.671.

[28] H. Stefansson, A.O. Roel, S. Steinberg, A.A. Ole, S. Cichon, D. Rujecsu and et al.: Nature. Vol. 460 (2009), p.744.

[29] B.B. Quednow, U. Ettinger, R. Mossner, D. Rujescu, I. Giegling, D.A. Collier and et al.: The J. of Neurosci. Vol. 31 (2011), p.6684

[30] L. Lennertz, B.B. Quednow, J. Benninghoff, M. Wagner, W. Maier and R. Mossner: Neuropsychobiol. Vol. 63 (2011), p.131

[31] S.Hwang, S.W. Son and S.C. Kim: J. Theor. Biol. Vol. 252 (2008), p.722

[32] E.E. Schadt and P.Y. Lum: J. Lipid Res. Vol. 47 (2006), p.2601

[33] D. Baldassarre, E. Grossi, M Buscema, M. Intraligi, M. Amato, E. Tremoli and et al.: Ann. Med. Vol. 36 (2004), p.630

[34] S. Dhanushkodi, G. Sahoo and N. Sarawanan: Int. J. Biometrics & Bioinformatics. Vol. 3 (2009), p.10

[35] H. Mutoh, N. Hamajima and K. Tajima. Chem-BioInformatics Journal Vol. 5 (2005), p.15

[36] Y. Tomita, S. Tomida, Y. Suzuki et al: Genome Informatics Vol. 14 (2003), p.593

[37] J. Yu and X.-W. Chen: Bioinformatics Vol. 21 (2005), p. i487

[38] S.-B. Cho and H.H. Won: Appl. Intell. Vol. 26 (2007), p.243

[39] D. Lawrence, L.H.A. Watkins, B.J. Sahakian, J.R. Hodges and T.W. Robbins: Brains Vol. 123 (2000), p.1349

[40] D. Wu, K. Warwick, Z. Ma, M.N. Gasson, J.G. Burgerss, S. Pan and T.Z. Aziz: International Journal of Neural Systems Vol. 20 (2010), p.109